Open AccessPS155. Long-term safety of adjunctive brexpiprazole (OPC-34712) in MDD: results from two 52-week open-label studies
Author(s) -
Craig Nelson,
Aleksandar Skuban,
Peter Zhang,
Emmanuelle Weiller,
Catherine Weiss
Publication year - 2016
Publication title -
the international journal of neuropsychopharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 107
eISSN - 1469-5111
pISSN - 1461-1457
DOI - 10.1093/ijnp/pyw043.155
Subject(s) - adjunctive treatment , medicine , major depressive disorder , pharmacology , open label , psychology , psychiatry , adverse effect , mood
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom